<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39449389</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2673-3986</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Epidemiologia (Basel, Switzerland)</Title><ISOAbbreviation>Epidemiologia (Basel)</ISOAbbreviation></Journal><ArticleTitle>Cycle Threshold Values of SARS-CoV-2 RT-PCR during Outbreaks in Nursing Homes: A Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>658</StartPage><EndPage>668</EndPage><MedlinePgn>658-668</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/epidemiologia5040046</ELocationID><Abstract><AbstractText Label="UNLABELLED">Backgound/Objectives: Cycle threshold (Ct) values of SARS-CoV-2 real-time reverse transcriptase-polymerase chain reaction (RT-PCR) tests are associated with infectivity and viral load, and they could be an aid in forecasting the evolution of SARS-CoV-2 outbreaks. The objective was to know the Ct values related to the incidence and reinfection of SARS-CoV-2 in successive outbreaks, which took place in nursing homes in Castellon (Spain) during 2020-2022, and to test its usefulness as an instrument of epidemic surveillance in nursing homes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">a retrospective cohort design with Poisson regression and multinomial logistic regression were used.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We studied four nursing home SARS-CoV-2 outbreaks, and the average infection rate, reinfection rate, and case fatality were 72.7%, 19.9%, and 5.5%, respectively; 98.9% of residents were vaccinated with three doses of a mRNA SARS-CoV-2 vaccine. Ct values for first infections and reinfections were 27.1 ± 6.6 and 31.9 ± 5.4 (<i>p</i> = 0.000). Considering Ct values ≥ 30 versus &lt;30, residents with reinfections had Ct values higher than residents with a first infection, an adjusted relative risk of 1.66 (95% Confidence interval 1.10-2.51). A sensitivity analysis confirmed these results.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Reinfection and SARS-CoV-2 vaccination (hybrid immunity) could protect against severe disease better than vaccination alone. High Ct values suggest lower transmission and severity. Its value can be useful for surveillance and forecasting future SARS-CoV-2 epidemics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gascó-Laborda</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Epidemiology Division, Public Health Center, 12003 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Fortuño</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3961-1293</Identifier><AffiliationInfo><Affiliation>Microbiology Laboratory, Universitary Hospital de la Plana, 12540 Vila-Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tirado-Balaguer</LastName><ForeName>Maria Dolores</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0003-3808-7300</Identifier><AffiliationInfo><Affiliation>Microbiology Laboratory, Universitary General Hospital, 12004 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meseguer-Ferrer</LastName><ForeName>Noemi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Epidemiology Division, Public Health Center, 12003 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabalza-Baztán</LastName><ForeName>Oihana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Microbiology Laboratory, Universitary General Hospital, 12004 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérez-Olaso</LastName><ForeName>Óscar</ForeName><Initials>Ó</Initials><Identifier Source="ORCID">0000-0002-3955-8234</Identifier><AffiliationInfo><Affiliation>Microbiology Laboratory, Universitary Hospital de la Plana, 12540 Vila-Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gómez-Alfaro</LastName><ForeName>Iris</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Microbiology Laboratory, Universitary General Hospital, 12004 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poujois-Gisbert</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Microbiology Laboratory, Universitary Hospital de la Plana, 12540 Vila-Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernández-Pérez</LastName><ForeName>Noelia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Microbiology Laboratory, Universitary Hospital de la Plana, 12540 Vila-Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lluch-Bacas</LastName><ForeName>Lledó</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Epidemiology Division, Public Health Center, 12003 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusen</LastName><ForeName>Viorica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Epidemiology Division, Public Health Center, 12003 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnedo-Pena</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1071-0984</Identifier><AffiliationInfo><Affiliation>Epidemiology Division, Public Health Center, 12003 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Health Sciences, Public University Navarra, 31006 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health and Epidemiology, Centro Investigación Biomédica en Red España (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellido-Blasco</LastName><ForeName>Juan Bautista</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Epidemiology Division, Public Health Center, 12003 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health and Epidemiology, Centro Investigación Biomédica en Red España (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, School of Medicine, Jaume I University, 12006 Castelló de la Plana, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Epidemiologia (Basel)</MedlineTA><NlmUniqueID>9918333886406676</NlmUniqueID><ISSNLinking>2673-3986</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PCR</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cycle threshold</Keyword><Keyword MajorTopicYN="N">infections</Keyword><Keyword MajorTopicYN="N">nursing homes</Keyword><Keyword MajorTopicYN="N">outbreaks</Keyword><Keyword MajorTopicYN="N">retrospective cohort</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>2</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39449389</ArticleId><ArticleId IdType="pmc">PMC11503345</ArticleId><ArticleId IdType="doi">10.3390/epidemiologia5040046</ArticleId><ArticleId IdType="pii">epidemiologia5040046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rao S.N., Manissero D., Steele V.R., Pareja J. A systematic review of the clinical utility of cycle threshold values in the context COVID-19. Infect. Dis. Ther. 2020;9:573–586. doi: 10.1007/s40121-020-00324-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-020-00324-3</ArticleId><ArticleId IdType="pmc">PMC7386165</ArticleId><ArticleId IdType="pubmed">32725536</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranha C., Patel V., Bhor V., Gogoi D. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients. J. Med. Virol. 2021;93:6794–6797. doi: 10.1002/jmv.27206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27206</ArticleId><ArticleId IdType="pmc">PMC8426941</ArticleId><ArticleId IdType="pubmed">34264527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J., Yuen A., Rhoades J., Barnes D., Zakowski P., Megna D.J., Catarino P., Zaffiri L., Rampolla R. Real-time transcription polymerase chain reaction cycle threshold values as criteria for utilization of incidental COVID-19 positive lung donors. J. Heart Lung Transpl. 2022;42:301–304. doi: 10.1016/j.healun.2022.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2022.12.016</ArticleId><ArticleId IdType="pmc">PMC9794393</ArticleId><ArticleId IdType="pubmed">36624019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Hansel D.E., Curlin M.E., Townes J.M., Messer W.B., Fan G., Qin X. Bimodal distribution pattern associated with the PCR cycle threshold (Ct) and implications in COVID-19 infections. Sci. Rep. 2022;12:14544. doi: 10.1038/s41598-022-18735-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18735-2</ArticleId><ArticleId IdType="pmc">PMC9406279</ArticleId><ArticleId IdType="pubmed">36008543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopera T.J., Alzate-Ángel J.C., Díaz F.J., Rugeles M.T., Aguilar-Jiménez W. The usefulness of antigen testing in predicting contagiousness in COVID-19. Microbiol. Spectr. 2022;10:e0196221. doi: 10.1128/spectrum.01962-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01962-21</ArticleId><ArticleId IdType="pmc">PMC9045251</ArticleId><ArticleId IdType="pubmed">35348350</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Raddad L.J., Chemaitelly H., Ayoub H.H., Tang P., Coyle P., Hasan M.R., Yassine H.M., Benslimane F.M., Al-Khatib H.A., Al-Kanaani Z., et al. Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections. Nat. Commun. 2022;13:532. doi: 10.1038/s41467-022-28199-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28199-7</ArticleId><ArticleId IdType="pmc">PMC8795418</ArticleId><ArticleId IdType="pubmed">35087035</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips M.C., Quintero D., Wald-Dickler N., Holtom P., Butler-Wu S.M. SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases. J. Clin. Virol. 2022;150–151:105153. doi: 10.1016/j.jcv.2022.105153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2022.105153</ArticleId><ArticleId IdType="pmc">PMC8990441</ArticleId><ArticleId IdType="pubmed">35472751</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier H.E., Plazaola M., Lopez R., Sanchez N., Saborio S., Ojeda S., Barilla C., Kuan G., Balmaseda A., Gordon A. SARS-CoV-2 infection-induced immunity and the duration of viral shedding: Results from a Nicaraguan household cohort study. Influenza Other Respir. Viruses. 2023;17:e13074. doi: 10.1111/irv.13074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13074</ArticleId><ArticleId IdType="pmc">PMC9835439</ArticleId><ArticleId IdType="pubmed">36457275</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsley H., Gahir J., Russell T.W., Greenwood D., Carr E.J., Dyke M., Adams L., Miah M., Clayton B., Smith C., et al. COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history. PLoS ONE. 2024;19:e0294897. doi: 10.1371/journal.pone.0294897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0294897</ArticleId><ArticleId IdType="pmc">PMC10956747</ArticleId><ArticleId IdType="pubmed">38512960</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimball A., Hatfield K.M., Arons M., James A., Taylor J., Spicer K., Bardossy A.C., Oakley L.P., Tanwar S., Chisty Z., et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:377–381. doi: 10.15585/mmwr.mm6913e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6913e1</ArticleId><ArticleId IdType="pmc">PMC7119514</ArticleId><ArticleId IdType="pubmed">32240128</ArticleId></ArticleIdList></Reference><Reference><Citation>Arons M.M., Hatfield K.M., Reddy S.C., Kimball A., James A., Jacobs J.R., Taylor J., Spicer K., Bardossy A.C., Oakley L.P., et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N. Engl. J. Med. 2020;382:2081–2090. doi: 10.1056/NEJMoa2008457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2008457</ArticleId><ArticleId IdType="pmc">PMC7200056</ArticleId><ArticleId IdType="pubmed">32329971</ArticleId></ArticleIdList></Reference><Reference><Citation>Paap K.C., van Loon A.M., Koene F.M., van Buul L.W., Jurriaans S., Smalbrugge M., de Jong M.D., Hertogh C.M.P.M. Clinical evaluation of single-swab sampling for rapid COVID-19 detection in outbreak settings in Dutch nursing homes. Eur. Geriatr. Med. 2022;13:711–718. doi: 10.1007/s41999-021-00584-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-021-00584-3</ArticleId><ArticleId IdType="pmc">PMC8602523</ArticleId><ArticleId IdType="pubmed">34797552</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung H.Y., Jian M.J., Chang C.K., Lin J.C., Yeh K.M., Chen C.W., Hsieh S.S., Hung K.S., Tang S.H., Perng C.L., et al. Emergency SARS-CoV-2 variants of concern: Novel multiplex real-time RT-PCR assay for rapid detection and surveillance. Microbiol. Spectr. 2022;10:e0251321. doi: 10.1128/spectrum.02513-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02513-21</ArticleId><ArticleId IdType="pmc">PMC8865422</ArticleId><ArticleId IdType="pubmed">35196812</ArticleId></ArticleIdList></Reference><Reference><Citation>Tso C.F., Garikipati A., Green-Saxena A., Mao Q., Das R. Correlation of population SARS-CoV-2 cycle threshold values to local disease dynamics: Exploratory observational study. JMIR Public Health Surveill. 2021;7:e28265. doi: 10.2196/28265.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28265</ArticleId><ArticleId IdType="pmc">PMC8176948</ArticleId><ArticleId IdType="pubmed">33999831</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison R.E., Hamada A., Haswell N., Groves A., Vihta K.D., Cella K., Garner S., Walker A.S., Seale A.C. Cycle threshold values as indication of increasing SARS-CoV-2 new variants, England, 2020–2022. Emerg. Infect. Dis. 2023;29:2024–2031. doi: 10.3201/eid2910.230030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2910.230030</ArticleId><ArticleId IdType="pmc">PMC10521603</ArticleId><ArticleId IdType="pubmed">37678158</ArticleId></ArticleIdList></Reference><Reference><Citation>Konetzka R.T., White E.M., Pralea A., Grabowski D.C., Mor V. A systematic review of long-term care facility characteristics associated with COVID-19 outcomes. J. Am. Geriatr. Soc. 2021;69:2766–2777. doi: 10.1111/jgs.17434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17434</ArticleId><ArticleId IdType="pmc">PMC8631348</ArticleId><ArticleId IdType="pubmed">34549415</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnedo-Pena A., Romeu-Garcia M.A., Gascó-Laborda J.C., Meseguer-Ferrer N., Safont-Adsuara L., Prades-Vila L., Flores-Medina M., Rusen V., Tirado-Balaguer M.D., Sabater-Vidal S., et al. Incidence, mortality, and risk factors of COVID-19 in nursing homes. Epidemiologia. 2022;3:179–190. doi: 10.3390/epidemiologia3020014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/epidemiologia3020014</ArticleId><ArticleId IdType="pmc">PMC9620907</ArticleId><ArticleId IdType="pubmed">36417250</ArticleId></ArticleIdList></Reference><Reference><Citation>Singanayagam A., Patel M., Charlett A., Lopez Bernal J., Saliba V., Ellis J., Ladhani S., Zambon M., Gopal R. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill. 2020;25:2001483. doi: 10.2807/1560-7917.ES.2020.25.32.2001483.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.32.2001483</ArticleId><ArticleId IdType="pmc">PMC7427302</ArticleId><ArticleId IdType="pubmed">32794447</ArticleId></ArticleIdList></Reference><Reference><Citation>Girón Pérez D.A., Fonseca-Agüero A., Toledo-Ibarra G.A., Gomez-Valdivia J.J., Díaz-Resendiz K.J.G., Benitez-Trinidad A.B., Razura-Carmona F.F., Navidad-Murrieta M.S., Covantes-Rosales C.E., Giron-Pérez M.I. Post-COVID-19 syndrome in outpatients and its association with viral load. Int. J. Environ. Res. Public Health. 2022;19:15145. doi: 10.3390/ijerph192215145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192215145</ArticleId><ArticleId IdType="pmc">PMC9690223</ArticleId><ArticleId IdType="pubmed">36429864</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyre D.W., Taylor D., Purver M., Chapman D., Fowler T., Pouwels K.B., Walker A.S., Peto T.E.A. Effect of COVID-19 vaccination on transmission of Alpha and Delta variants. N. Engl. J. Med. 2022;386:744–756. doi: 10.1056/NEJMoa2116597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116597</ArticleId><ArticleId IdType="pmc">PMC8757571</ArticleId><ArticleId IdType="pubmed">34986294</ArticleId></ArticleIdList></Reference><Reference><Citation>McEllistrem M.C., Clancy C.J., Buehrle D.J., Lucas A., Decker B.K. Single dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic coronavirus disease 2019 (COVID-19) Clin. Infect. Dis. 2021;73:e1365–e1367. doi: 10.1093/cid/ciab263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab263</ArticleId><ArticleId IdType="pmc">PMC8083695</ArticleId><ArticleId IdType="pubmed">33768222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor M., Kalita D., Panda P.K. Cycle threshold values versus reverse transcription-polymerase chain reaction positivity in COVID-19 de-isolation. Indian J. Med. Microbiol. 2021;39:133–135. doi: 10.1016/j.ijmmb.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmmb.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7834072</ArticleId><ArticleId IdType="pubmed">33610247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wünsch K., Anastasiou O.E., Alt M., Brochhagen L., Cherneha M., Thümmler L., van Baal L., Madel R.J., Lindemann M., Taube C., et al. COVID-19 in elderly, immunocompromised or diabetic patients-From immune monitoring to clinical management in the hospital. Viruses. 2022;14:746. doi: 10.3390/v14040746.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040746</ArticleId><ArticleId IdType="pmc">PMC9024512</ArticleId><ArticleId IdType="pubmed">35458476</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay S.L., Tobolowsky F.A., Moritz E.D., Hatfield K.M., Bhatnagar A., LaVoie S.P., Jackson D.A., Lecy K.D., Bryant-Genevier J., Campbell D., et al. Performance evaluation of serial SARS-CoV-2 rapid antigen testing during a nursing home outbreak. Ann. Intern. Med. 2021;174:945–951. doi: 10.7326/M21-0422.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0422</ArticleId><ArticleId IdType="pmc">PMC8108910</ArticleId><ArticleId IdType="pubmed">33900791</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitão I.C., Calil P.T., Galliez R.M., Moreira F.R.R., Mariani D., Castiñeiras A.C.P., da Silva G.P.D., Maia R.A., Corrêa I.A., Monteiro F.L.L., et al. Prolonged SARS-CoV-2 positivity in immunocompetent patients: Virus isolation, genomic integrity, and transmission risk. Microbiol. Spectr. 2021;9:e0085521. doi: 10.1128/Spectrum.00855-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00855-21</ArticleId><ArticleId IdType="pmc">PMC8597635</ArticleId><ArticleId IdType="pubmed">34787498</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoaib N., Noureen N., Faisal A., Zaheer M., Imran M., Ahsan A., Munir R., Zaidi N. Factors associated with cycle threshold values (Ct-values) of SARS-CoV2-rRT-PCR. Mol. Biol. Rep. 2022;49:4101–4106. doi: 10.1007/s11033-022-07360-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07360-x</ArticleId><ArticleId IdType="pmc">PMC8943503</ArticleId><ArticleId IdType="pubmed">35325359</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoads D.D., Pinsky B.A. The truth about SARS-CoV-2 cycle threshold values is rarely pure and never simple. Clin. Chem. 2021;68:16–18. doi: 10.1093/clinchem/hvab146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvab146</ArticleId><ArticleId IdType="pubmed">34314495</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan G., Jin Y., Wang Q., Yue Y. Assessing the comparability of cycle threshold values derived from five external quality assessment rounds for Omicron nucleic acid testing. Virol. J. 2023;20:119. doi: 10.1186/s12985-023-02032-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02032-z</ArticleId><ArticleId IdType="pmc">PMC10249569</ArticleId><ArticleId IdType="pubmed">37291570</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip C.C., Sridhar S., Cheng A.K., Leung K.H., Choi G.K., Chen J.H., Poon R.W., Chan K.H., Wu A.K., Chan H.S., et al. Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection. J. Clin. Virol. 2020;129:104476. doi: 10.1016/j.jcv.2020.104476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104476</ArticleId><ArticleId IdType="pmc">PMC7255195</ArticleId><ArticleId IdType="pubmed">32516739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministerio de Sanidad  Estrategia de Detección Precoz, Vigilancia y Control de COVID-19. Centro de Coordinación de Alertas y Emergencias Sanitarias. Ministry of Health. Strategy for Early Detection Surveillance and Control of COVID-19. Health Alerts and Emergencies Coordination Center. Actualizado 22 de Diciembre de 2021.  [(accessed on 28 June 2024)]; Available online:  https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf.</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control Reinfection with SARS-CoV-2: Implementation of a Surveillance Case Definition within the EU/EEA. 2021.  [(accessed on 20 June 2022)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/reinfection-sars-cov-2-implementation-surveillance-case-definition-within-eueea.</Citation></Reference><Reference><Citation>Khorraminejad-Shirazi M., Nabavizadeh S.S., Aminnia S., Ahmadifar M., Borazjani R., Sadeghi E., Izadpanah S., Heidari Esfahani M., Mokhtari M., Monabati A. Association of demographic, clinical, and vaccination characteristics with COVID-19 viral load assessed by qRT-PCR. Arch. Iran Med. 2023;26:688–694. doi: 10.34172/aim.2023.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/aim.2023.101</ArticleId><ArticleId IdType="pmc">PMC10915925</ArticleId><ArticleId IdType="pubmed">38431949</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimcheff D.E., Blair C.N., Zhu Y., Chappell J.D., Gaglani M., McNeal T., Ghamande S., Steingrub J.S., Shapiro N.I., Duggal A., et al. Total and subgenomic RNA viral load in patients infected with SARS-CoV-2 Alpha, Delta, and Omicron variants. J. Infect. Dis. 2023;228:235–244. doi: 10.1093/infdis/jiad061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad061</ArticleId><ArticleId IdType="pmc">PMC10420395</ArticleId><ArticleId IdType="pubmed">36883903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindran S., Gubbay J.B., Cronin K., Sullivan A., Zygmunt A., Johnson K., Buchan S.A., Parpia A.S. Association between cycle threshold value and vaccination status among severe acute respiratory syndrome coronavirus 2 Omicron variant cases in Ontario, Canada, in December 2021. Open Forum Infect. Dis. 2023;10:ofad282. doi: 10.1093/ofid/ofad282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad282</ArticleId><ArticleId IdType="pmc">PMC10234392</ArticleId><ArticleId IdType="pubmed">37274182</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Liu Y.K., Sun Q.D., Du Z., Fang Y.Q., Guo F., Wang Y.B., He Y., Cen Y., Zeng F. Clinical characteristics and risk factors for a prolonged length of stay of patients with asymptomatic and mild COVID-19 during the wave of Omicron from Shanghai, China. BMC Infect. Dis. 2022;22:947. doi: 10.1186/s12879-022-07935-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07935-w</ArticleId><ArticleId IdType="pmc">PMC9756685</ArticleId><ArticleId IdType="pubmed">36526990</ArticleId></ArticleIdList></Reference><Reference><Citation>Textor J., van der Zander B., Gilthorpe M.S., Liskiewicz M., Ellison G.T. Robust causal inference using directed acyclic graphs: The R package ‘dagitty’. Int. J. Epidemiol. 2016;45:1887–1894. doi: 10.1093/ije/dyw341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw341</ArticleId><ArticleId IdType="pubmed">28089956</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer E.D., Sandfort M., Bender J., Matysiak-Klose D., Dörre A., Bojara G., Beyrer K., Hellenbrand W. BNT162b2 vaccination reduced infections and transmission in a COVID-19 outbreak in a nursing home in Germany, 2021. Influenza Other Respir. Viruses. 2023;17:e13051. doi: 10.1111/irv.13051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13051</ArticleId><ArticleId IdType="pmc">PMC9538000</ArticleId><ArticleId IdType="pubmed">36082799</ArticleId></ArticleIdList></Reference><Reference><Citation>Admon A.J., Wander P.L., Iwashyna T.J., Ioannou G.N., Boyko E.J., Hynes D.M., Bowling C.B., Bohnert A.S.B., O’Hare A.M., Smith V.A., et al. Consensus elements for observational research on COVID-19-related long-term outcomes. Medicine. 2022;101:e31248. doi: 10.1097/MD.0000000000031248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000031248</ArticleId><ArticleId IdType="pmc">PMC9678399</ArticleId><ArticleId IdType="pubmed">36401423</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínek J., Tomášková H., Janošek J., Zelená H., Kloudová A., Mrázek J., Ježo E., Král V., Pohořská J., Šturcová H., et al. Immune response 5–7 months after vaccination against SARS-CoV-2 in elderly nursing home residents in the Czech Republic: Comparison of three vaccines. Viruses. 2022;14:1086. doi: 10.3390/v14051086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051086</ArticleId><ArticleId IdType="pmc">PMC9147580</ArticleId><ArticleId IdType="pubmed">35632827</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncombe T.R., Garrod M., Wang X., Ng J., Lee E., Short K., Tan K. Risk factors associated with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission, outbreak duration, and mortality in acute-care settings. Infect. Control Hosp. Epidemiol. 2023;44:1643–1649. doi: 10.1017/ice.2023.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2023.19</ArticleId><ArticleId IdType="pmc">PMC10587374</ArticleId><ArticleId IdType="pubmed">36815248</ArticleId></ArticleIdList></Reference><Reference><Citation>American Association for Clinical Chemistry  Recommendation for Reporting SARS-CoV-2 Cycle Threshold (CT) Values.  [(accessed on 1 March 2023)].  Available online:  https://www.myadlm.org/Media/Press-Release-Archive/2021/07-Jul/AACC-Recommends-Against-Using-Coronavirus-Test-Ct-Values-to-Guide-COVID19-Patient-Care.</Citation></Reference><Reference><Citation>Quiroz-Ruiz H.R., Chimoy-Effio P.J., Vértiz-Osores J.J., Bazán-Mayra J.E. Correlación entre el umbral de ciclo de la RPC en tiempo real y la clasificación clínica de la COVID-19. Rev. Chilena Infectol. 2022;39:35–44. doi: 10.4067/S0716-10182022000100035.</Citation><ArticleIdList><ArticleId IdType="doi">10.4067/S0716-10182022000100035</ArticleId><ArticleId IdType="pubmed">35735278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley 14/1986, de 25 de Abril, General de Sanidad (Law General of Health)  [(accessed on 2 August 2021)].  Available online:  https://www.boe.es/eli/es/l/1986/04/25/14/con. (In Spanish)</Citation></Reference><Reference><Citation>Ley 16/2003, de 28 de Mayo, de Cohesión y Calidad del Sistema Nacional de Salud  (Law of Cohesion and Quality of the National System of Health)  [(accessed on 2 August 2021)].  Available online:  https://www.boe.es/eli/es/l/2003/05/28/16. (In Spanish)</Citation></Reference><Reference><Citation>Ley 33/2011, de 4 de Octubre, General de Salud Pública (Law General of Public Health)  [(accessed on 2 August 2021)].  Available online:  https://www.boe.es/eli/es/l/2011/10/04/33/con. (In Spanish)</Citation></Reference><Reference><Citation>Ministry of Health Agreed in the Interterritorial Council of the National Health System  Early Response Plan in a COVID-19 Pandemic Control Scenario.  [(accessed on 2 August 2021)];2020  Available online:  https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Plan_de_respuesta_temprana_escenario_control.pdf. (In Spanish)</Citation></Reference><Reference><Citation>Bobrovitz N., Ware H., Ma X., Li Z., Hosseini R., Cao C., Selemon A., Whelan M., Premji Z., Issa H., et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: A systematic review and meta-regression. Lancet Infect. Dis. 2023;23:556–567. doi: 10.1016/S1473-3099(22)00801-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00801-5</ArticleId><ArticleId IdType="pmc">PMC10014083</ArticleId><ArticleId IdType="pubmed">36681084</ArticleId></ArticleIdList></Reference><Reference><Citation>Gascó-Laborda J.C., Gil-Fortuño M., Ortiz-Rambla J., Meseguer-Ferrer N., Pérez-Olaso Ó., Lluch-Bacas L., Moya-Malo R., Moliner-Urdiales D., Bellido-Blasco J.B. COVID-19 outbreak in a properly vaccinated nursing home. Influence of hybrid immunity on viral load, risk of infection and risk of disease progression. Rev. Esp. Salud. Publica. 2024;98:e202405036.</Citation><ArticleIdList><ArticleId IdType="pubmed">38785412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauriz E., Fernández-Vázquez J.P., Díez-Flecha C., Reguero-Celada S., Fernández-Villa T., Fernández-Somoano A., Caylà J.A., Lozano-García J.A., Vázquez-Casares A.M., Martín-Sánchez V. Impact of a COVID-19 outbreak in an elderly care home after primary vaccination. Vaccines. 2023;11:1382. doi: 10.3390/vaccines11081382.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11081382</ArticleId><ArticleId IdType="pmc">PMC10459698</ArticleId><ArticleId IdType="pubmed">37631950</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques H.R., Sousa D., Faria J., Pinto J., Costa A., Henriques M.A., Durão M.C. Learning from the COVID-19 outbreaks in long-term care facilities: A systematic review. BMC Geriatr. 2023;23:618. doi: 10.1186/s12877-023-04319-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-023-04319-w</ArticleId><ArticleId IdType="pmc">PMC10546730</ArticleId><ArticleId IdType="pubmed">37784017</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers E., Deschepper E., Duysburgh E., De Rop L., De Burghgraeve T., Van Ngoc P., Digregorio M., Delogne S., Coen A., De Clercq N., et al. Declining prevalence of SARS-CoV-2 antibodies among vaccinated nursing home residents and staff six months after the primary BNT162b2 vaccination campaign in Belgium: A prospective cohort study. Viruses. 2022;14:2361. doi: 10.3390/v14112361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112361</ArticleId><ArticleId IdType="pmc">PMC9696089</ArticleId><ArticleId IdType="pubmed">36366456</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyet J., Helle F., Bourdenet G., Joseph C., Gubler B., Deschasse G., Defouilloy I., Slovenski T., François C., Liabeuf S., et al. Kinetics of SARS-CoV-2-neutralising antibodies of residents of long-term care facilities. J. Nutr. Health Aging. 2022;26:57–63. doi: 10.1007/s12603-021-1713-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-021-1713-4</ArticleId><ArticleId IdType="pmc">PMC8683825</ArticleId><ArticleId IdType="pubmed">35067704</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen J., Jhala D. COVID-19 cycle threshold/cycle number testing at a community living center. Fed. Pract. 2022;39:254–260. doi: 10.12788/fp.0276.</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/fp.0276</ArticleId><ArticleId IdType="pmc">PMC9648608</ArticleId><ArticleId IdType="pubmed">36404943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennon N.J., Bhattacharyya R.P., Mina M.J., Rehm H.L., Hung D.T., Smole S., Woolley A., Lander E.S., Gabriel S.B. Cross-Sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities. J. Infect. Dis. 2021;224:1658–1663. doi: 10.1093/infdis/jiab367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab367</ArticleId><ArticleId IdType="pmc">PMC8420626</ArticleId><ArticleId IdType="pubmed">34255846</ArticleId></ArticleIdList></Reference><Reference><Citation>Paap K.C., van Loon A.M., van Rijs S.M., Helmich E., Buurman B.M., Smalbrugge M., Hertogh C.M.P.M. Symptom- and prevention-based testing of COVID-19 in nursing home residents: A retrospective cohort study. Gerontol. Geriatr. Med. 2021;7:23337214211055338. doi: 10.1177/23337214211055338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23337214211055338</ArticleId><ArticleId IdType="pmc">PMC8591646</ArticleId><ArticleId IdType="pubmed">34790840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson W.W., Hatfield K.M., Tressler S., Bicking Kinsey C., Parra G., Zell R., Denson A., Williams C., Spicer K.B., Kamal-Ahmed I., et al. Characteristics of nursing home residents and healthcare personnel with repeated severe acute respiratory coronavirus virus 2 (SARS-CoV-2) tests positive ≥90 days after initial infection: Four US jurisdictions, July 2020–March 2021. Infect. Control Hosp. Epidemiol. 2023;44:809–812. doi: 10.1017/ice.2022.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2022.62</ArticleId><ArticleId IdType="pmc">PMC9433708</ArticleId><ArticleId IdType="pubmed">35591770</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrotri M., Krutikov M., Palmer T., Giddings R., Azmi B., Subbarao S., Fuller C., Irwin-Singer A., Davies D., Tut G., et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): A prospective cohort study. Lancet Infect. Dis. 2021;21:1529–1538. doi: 10.1016/S1473-3099(21)00289-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00289-9</ArticleId><ArticleId IdType="pmc">PMC8221738</ArticleId><ArticleId IdType="pubmed">34174193</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B.N., Cooper L., Beck J.J., Finnicum C.T., Davis C.M., Van Asselt A.J., Kallsen N., Silvernail C., Viet S., Long K., et al. More than results: The clinical and research relationship in the evolving detection and surveillance of SARS-CoV-2. S. D. Med. 2023;76:248–256.</Citation><ArticleIdList><ArticleId IdType="pubmed">37732913</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoaib N., Iqbal A., Shah F.A., Zainab W., Qasim M., Zerqoon N., Naseem M.O., Munir R., Zaidi N. Population-level median cycle threshold (Ct) values for asymptomatic COVID-19 cases can predict the trajectory of future cases. PLoS ONE. 2023;18:e0281899. doi: 10.1371/journal.pone.0281899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281899</ArticleId><ArticleId IdType="pmc">PMC9997994</ArticleId><ArticleId IdType="pubmed">36893098</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehesh P., Baradaran H.R., Eshrati B., Motevalian S.A., Salehi M., Donyavi T. The relationship between population-level SARS-CoV-2 cycle threshold values and trend of COVID-19 infection: Longitudinal study. JMIR Public Health Surveill. 2022;8:e36424. doi: 10.2196/36424.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/36424</ArticleId><ArticleId IdType="pmc">PMC9645421</ArticleId><ArticleId IdType="pubmed">36240022</ArticleId></ArticleIdList></Reference><Reference><Citation>Boogaerts H.L.F., Smits P., Hans G., Bouly L., Coeck E., Vandamme S., Jansens H., Goossens H., Matheeussen V. Laboratory analysis of two Delta SARS-CoV-2 variant outbreaks in the Port of Antwerp. Acta. Clin. Belg. 2022;77:925–932. doi: 10.1080/17843286.2021.2010966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17843286.2021.2010966</ArticleId><ArticleId IdType="pubmed">34851231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyaruaba R., Mwaliko C., Dobnik D., Neužil P., Amoth P., Mwau M., Yu J., Yang H., Wei H. Digital PCR Applications in the SARS-CoV-2/COVID-19 era: A roadmap for future outbreaks. Clin. Microbiol. Rev. 2022;35:e0016821. doi: 10.1128/cmr.00168-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.00168-21</ArticleId><ArticleId IdType="pmc">PMC9491181</ArticleId><ArticleId IdType="pubmed">35258315</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda R.L., Guterres A., de Azeredo Lima C.H., Filho P.N., Gadelha M.R. Misinterpretation of viral load in COVID-19 clinical outcomes. Virus Res. 2021;296:198340. doi: 10.1016/j.virusres.2021.198340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2021.198340</ArticleId><ArticleId IdType="pmc">PMC7881726</ArticleId><ArticleId IdType="pubmed">33592214</ArticleId></ArticleIdList></Reference><Reference><Citation>Han M.S., Byun J.H., Cho Y., Rim J.H. RT-PCR for SARS-CoV-2: Quantitative versus qualitative. Lancet Infect. Dis. 2021;21:165. doi: 10.1016/S1473-3099(20)30424-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30424-2</ArticleId><ArticleId IdType="pmc">PMC7239624</ArticleId><ArticleId IdType="pubmed">32445709</ArticleId></ArticleIdList></Reference><Reference><Citation>Infectious Disease Society of America and Association for Molecular Pathology Joint Statement on the Use of SARS-CoV-2 PCR Cycle Threshold (Ct) Values for Clinical Decision-Making.  [(accessed on 1 March 2024)].  Available online:  https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-amp-statement.pdf.</Citation></Reference><Reference><Citation>Michaelis S., Schneider C., Schnedl W.J., Baranyi A., Enko D. Comparison of cycle-threshold-values between two commercial SARS-CoV-2 PCR assays. EXCLI J. 2023;22:397–399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10279969</ArticleId><ArticleId IdType="pubmed">37346804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahdouh E., Lázaro-Perona F., Romero-Gómez M.P., Mingorance J., García-Rodriguez J. Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load. J. Infect. 2021;82:414–451. doi: 10.1016/j.jinf.2020.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.10.017</ArticleId><ArticleId IdType="pmc">PMC7585367</ArticleId><ArticleId IdType="pubmed">33131699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingberg E., Ahlstrand E., Cajander P., Löf E., Sundqvist M., Wegener M., Lidén M., Cajander S. RT-PCR cycle threshold value in combination with visual scoring of chest computed tomography at hospital admission predicts outcome in COVID-19. Infect. Dis. 2022;54:431–440. doi: 10.1080/23744235.2022.2035428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2035428</ArticleId><ArticleId IdType="pubmed">35114897</ArticleId></ArticleIdList></Reference><Reference><Citation>Markewitz R., Dargvainiene J., Junker R., Wandinger K.P. Cycle threshold of SARS-CoV-2 RT-PCR as a driver of retesting. Sci. Rep. 2024;14:2423. doi: 10.1038/s41598-024-52984-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-52984-7</ArticleId><ArticleId IdType="pmc">PMC10825127</ArticleId><ArticleId IdType="pubmed">38287120</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchta C., Görzer I., Chiba P., Camp J.V., Holzmann H., Puchhammer-Stöckl E., Mayerhofer M., Müller M.M., Aberle S.W. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR. Clin. Chem. Lab. Med. 2020;59:987–994. doi: 10.1515/cclm-2020-1602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-1602</ArticleId><ArticleId IdType="pubmed">33554519</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>